Bevacizumab (Avastin) therapy in combination with carboplatin and weekly paclitaxel for advanced non-squamous non-small cell lung cancer.
Phase of Trial: Phase II
Latest Information Update: 12 May 2017
At a glance
- Drugs Bevacizumab (Primary) ; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 10 May 2017 Status changed from recruiting to completed.
- 19 Jan 2012 New trial record